Amarin Corporation plc

The momentum for this stock is not very good. Amarin Corporation plc is not very popular among insiders. Amarin Corporation plc is a mediocre stock to choose.
Log in to see more information.
Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and developm...

News

Research Highlighting the Clinical Impact of VASCEPA /VAZKEPA (icosapent ethyl) in Patients with Diabetes and High Cardiovascular Risk and the Anti-Lp(a) Oxidation Mechanistic Effect of Eicos
Research Highlighting the Clinical Impact of VASCEPA /VAZKEPA (icosapent ethyl) in Patients with Diabetes and High Cardiovascular Risk and the Anti-Lp(a) Oxidation Mechanistic Effect of Eicos

Globe Newswire DUBLIN, Ireland and BRIDGEWATER, N.J., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that new supported and/or funded research on the clinical impact of...\n more…

Amarin (NASDAQ:AMRN) & SIGA Technologies (NASDAQ:SIGA) Financial Survey
Amarin (NASDAQ:AMRN) & SIGA Technologies (NASDAQ:SIGA) Financial Survey

Zolmax Amarin (NASDAQ:AMRN - Get Free Report) and SIGA Technologies (NASDAQ:SIGA - Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies...\n more…

Zacks Research Research Analysts Lift Earnings Estimates for Amarin Co. plc (NASDAQ:AMRN)
Zacks Research Research Analysts Lift Earnings Estimates for Amarin Co. plc (NASDAQ:AMRN)

Ticker Report Amarin Co. plc (NASDAQ:AMRN - Free Report) - Research analysts at Zacks Research boosted their Q3 2024 EPS estimates for Amarin in a note issued to investors on Wednesday, August 21st. Zacks Research...\n more…

Latest Research Highlighting VASCEPA /VAZKEPA  (icosapent ethyl) REDUCE-IT  Subgroup Data and New Mechanistic Insights into Eicosapentaenoic Acid (EPA) to be Presented at European Society of
Latest Research Highlighting VASCEPA /VAZKEPA (icosapent ethyl) REDUCE-IT Subgroup Data and New Mechanistic Insights into Eicosapentaenoic Acid (EPA) to be Presented at European Society of

Globe Newswire DUBLIN, Ireland and BRIDGEWATER, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced new supported and/or funded subgroup data from the landmark REDUCE-IT...\n more…

Amarin Co. plc (NASDAQ:AMRN) CEO Aaron Berg Purchases 160,000 Shares of Stock
Amarin Co. plc (NASDAQ:AMRN) CEO Aaron Berg Purchases 160,000 Shares of Stock

Ticker Report Amarin Co. plc (NASDAQ:AMRN - Get Free Report) CEO Aaron Berg bought 160,000 shares of Amarin stock in a transaction dated Friday, August 2nd. The stock was acquired at an average cost of $0.64 per...\n more…

Amarin Co. plc Forecasted to Earn FY2024 Earnings of ($0.13) Per Share (NASDAQ:AMRN)
Amarin Co. plc Forecasted to Earn FY2024 Earnings of ($0.13) Per Share (NASDAQ:AMRN)

Zolmax Amarin Co. plc (NASDAQ:AMRN - Free Report) - Analysts at Cantor Fitzgerald upped their FY2024 earnings per share (EPS) estimates for shares of Amarin in a research note issued on Thursday, August...\n more…